NCT00167908View on ClinicalTrials.gov

Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

May 31, 2007

Conditions
Head and Neck Cancer
Interventions
DRUG

Ethyol (drug)

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00167908 - Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer | Biotech Hunter | Biotech Hunter